| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |